Plain-English translation of NCT07571993 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Rheumatoid Arthritis research guide →HARMONICS is a long-term tracking study for people with rheumatoid arthritis who have achieved remission (when symptoms are well controlled) and are tapering down or stopping their conventional arthritis medications. Researchers will follow you regularly with clinical visits, ultrasound imaging, and X-rays to see how well you stay in remission and whether you need to restart treatment. The goal is to understand which patients can safely stay on lower doses or no medication, and which patients may need treatment again.
Many doctors and patients want to know if it's possible to reduce or stop arthritis medications once remission is achieved, but we don't have clear guidance on which patients can safely do this and what happens long-term. This study aims to answer those questions so doctors can make smarter, personalized decisions about treatment reduction.
You likely qualify if…
You likely don't qualify if…
After enrolling, you will continue your regular rheumatology care at the clinic while your medications are reduced or stopped according to your doctor's plan. You'll have routine visits (typically every few months) where doctors will examine your joints, perform ultrasound imaging, and possibly take X-rays to check your disease activity. The study will follow you for up to 5 years, unless your arthritis flares earlier—if that happens, you'll be monitored for an additional 12 months after the flare. All of this happens as part of your standard clinical care, and researchers will collect and store your data and optional blood samples to better understand remission.
AI-generated summary from trial data · Jun 23, 2026 · Not medical advice
Italy